3 days Ago By ABMN Staff
LifeMD, Inc. ( NASDAQ:LFMD – Get Free Report ) has been assigned a consensus rating of “Buy” from the six analysts that are covering the firm, MarketBeat.com reports.
Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have covered the stock in the last year is $12.00.
LFMD has been the subject of several analyst reports. B. Riley initiated coverage on shares of LifeMD in a report on Friday, August 23rd.
They set a “buy” rating and a $11.00 price target for the company. KeyCorp decreased their target price on shares of LifeMD from $12.
00 to $10.00 and set an “overweight” rating for the company in a research report on Thursday, July 11th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $15.
00 price target on shares of LifeMD in a report on Tuesday, August 20th. Read Our Latest Research Report on LFMD Institutional Inflows and Outflows LifeMD Trading Up 0.8 % NASDAQ LFMD opened at $5.
27 on Friday. The company has a debt-to-equity ratio of 10.83, a quick ratio of 0.
83 and a current ratio of 0.87. LifeMD has a one year low of $4.
05 and a one year high of $12.88. The company has a 50-day simple moving average of $5.
80 and a 200-day simple moving average of $7.91. The firm has a market capitalization of $220.
06 million, a PE ratio of -7.12 and a beta of 1.19.
LifeMD ( NASDAQ:LFMD – Get Free Report ) last issued its earnings results on Wednesday, August 7th. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.
13) by ($0.06). The business had revenue of $50.
66 million during the quarter, compared to the consensus estimate of $48.47 million. During the same period in the prior year, the firm posted ($0.
23) EPS. On average, equities analysts forecast that LifeMD will post -0.49 earnings per share for the current year.
About LifeMD ( Get Free Report LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. See Also Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.
com's FREE daily email newsletter ..
